Company: MDCXW
Filing Date: 2025-04-30
Form Type: 10-K/A
Source: 0001062993-25-008246
Chunk: 8

Company: Medicus Pharma Ltd.
Filing Date: 2025-04-30
Form: 10-K/A
Chunk 8
---
 to the shift in markets from cannabis to boutique pharma and drug development. In addition, Dr. May brings deep corporate governance experience through her work with both corporate and not for profit boards, including contributing to the public listing and uplisting process of several start up cannabis and boutique pharmaceutical companies. Dr. May has served on the board of directors of FV Pharma Inc. (2018 to 2020) and the board of directors of Cannara Biotech (2019 to 2020) where she chaired the Compensation Committee and was a member of the Corporate Governance Committee. She has also been a member of the YMCA Northumberland Charity Board (2020 to 2023) where she chaired the Finance Audit and Risk Committee and has been on the board of directors of Beacon Environmental since 2023. Dr. May received her Bachelor of Science (Honours) degree in Botany and Plant Genetics from the University of Guelph and her PhD in Evolutionary Genetics from Queen's University. Information Regarding Executive Officers

| Name             |     | Age |     | Position                                       |
| Dr. Raza Bokhari |     |  58 |     | Executive Chairman and Chief Executive Officer |
| Carolyn Bonner   |     |  41 |     | President                                      |
| James Quinlan    |     |  61 |     | Chief Financial Officer                        |

5

| Name               |     | Age |     | Position                                                                    |
| Dr. Edward Brennan |     |  65 |     | Chief Scientific Officer & Head of Research and development ("R&D") Program |
| Dr. Faisal Mehmud  |     |  50 |     | Chief Medical Officer                                                       |

Set forth below is certain information with respect to our current executive officers as of April 29, 2025. Dr. Raza Bokhari, Executive Chairman and Chief Executive Officer Dr. Bokhari's biography is set forth above. Carolyn Bonner, President Carolyn Bonner has served as our President since September 2023. Ms. Bonner until recently was the President & CEO of Parkway Clinical Laboratories (2019 to 2023), a College of American pathologist (CAP), accredited diagnostic company, serving healthcare providers across the United States. Ms. Bonner was the Director of Corporate Development at Building Beyond BRIC Investment Fund (2019 to 2023) where she was extensively involved in fundraising, marketing, and assisting with back-office operations from May 2009 to December 2011. Previously